Compare iShares 3 7 Year Treasury Bond ETF (IEI) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 3 7 Year Treasury Bond ETF vs Oscar Health Inc — how do they compare? iShares 3 7 Year Treasury Bond ETF trades at $116.37, while Oscar Health Inc trades at $29.22 (market cap $9.28B). The key difference: Oscar Health Inc is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| IEI | OSCR | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $120.72 | $32.18 |
52-Week Low | $116.45 | $10.85 |
Market Cap | — | $9.28B |
Enterprise Value | — | $4.90B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEI (iShares 3-7 Year Treasury Bond ETF) trades at $116.76, down 0.19% with a bearish technical signal from moving averages. The ETF focuses on intermediate-term U.S. Treasury bonds, offering lower volatility compared to corporate bond alternatives. Recent news highlights institutional selling by AlTi Global Inc. and competitive pressure from Vanguard's lower-cost bond ETFs.
The outlook remains cautious amid Federal Reserve uncertainty and rising inflation concerns. While Treasury ETFs provide safety during market stress, IEI faces headwinds from potential rate hikes and stronger-yielding alternatives. Key risks include interest rate sensitivity and investor preference for higher-yield bond options in the current environment.
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares 3 7 Year Treasury Bond ETF
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
